Medicare Enrolled
Dr. Sameer Gupta, MD, MPH
Hematology & Oncology · Bryn Mawr, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Gupta from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gupta?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gupta
Dr. Sameer Gupta is a hematology & oncology specialist in Bryn Mawr, PA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Gupta performed 297,171 Medicare services across 3,260 unique beneficiaries.
Between the years covered by Open Payments, Dr. Gupta received a total of $338,679 from 97 pharmaceutical and/or device companies across 1288 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gupta is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 1% volume in PA
$338,679 industry payments
Medicare Practice Summary
Medicare Utilization ↗297,171
Medicare services
Top 1% in PA for hematology & oncology
3,260
Unique beneficiaries
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~16,510 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
95,900 | $2 | $10 |
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
51,750 | $1 | $2 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
48,016 | $0 | $5 |
| Pembrolizumab injection (Keytruda) | 29,800 | $43 | $90 |
| Paclitaxel chemotherapy injection | 15,538 | $0 | $10 |
| Denosumab injection (Prolia/Xgeva) | 9,480 | $18 | $40 |
| Anti-nausea injection (ondansetron/Zofran) | 5,355 | $0 | $10 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
4,678 | $13 | $55 |
| Anti-nausea injection (Aloxi/palonosetron) | 3,941 | $1 | $50 |
| Pegfilgrastim-apgf injection An injection of pegfilgrastim-apgf, a biosimilar medication. The dose specified is 0.5 mg. |
3,881 | $88 | $370 |
| Immune globulin infusion (Octagam) This procedure involves the administration of immune globulin medication directly into a vein. It is provided in a non-lyophilized liquid form. |
3,300 | $34 | $70 |
| Iron infusion (Monoferric) | 3,200 | $15 | $45 |
| Injection, granisetron hydrochloride, 100 mcg | 2,825 | $0 | $25 |
| Injection, fulvestrant, 25 mg | 1,942 | $7 | $125 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,770 | $0 | $3 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,750 | $100 | $220 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
1,684 | $1 | $20 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,518 | $5 | $5 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
1,206 | $11 | $50 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
1,167 | $108 | $322 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
1,146 | $4 | $25 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 982 | $3 | $195 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
839 | $1 | $13 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
732 | $1 | $17 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
695 | $2 | $200 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
461 | $70 | $70 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
458 | $145 | $262 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
441 | $24 | $75 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
399 | $2 | $30 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
392 | $54 | $160 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
277 | $61 | $185 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
210 | $11 | $35 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
194 | $27 | $125 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
188 | $52 | $170 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
165 | $24 | $72 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
157 | $31 | $105 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
128 | $1 | $9 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
114 | $6 | $113 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
101 | $24 | $70 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
100 | $17 | $64 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
96 | $20 | $75 |
| New patient office visit, complex (60-74 min) | 91 | $178 | $309 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
43 | $61 | $150 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
32 | $80 | $171 |
| Biopsy of bone marrow | 16 | $136 | $385 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
13 | $132 | $250 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
20.6% high complexity
77.3% medium
2.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$338,679
Total received (2018-2024)
Avg $48,383/year across 7 years
Top 2% in PA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
97
Companies
1,288
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$318,680 (94.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,025 (4.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,975 (1.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$39,186
2023
$99,027
2022
$75,381
2021
$57,597
2020
$26,268
2019
$38,535
2018
$2,685
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$26,294
Daiichi Sankyo Inc.
$8,924
Astellas Pharma US Inc
$1,235
PFIZER INC.
$376
Merck Sharp & Dohme LLC
$217
ABBVIE INC.
$197
Novartis Pharmaceuticals Corporation
$196
E.R. Squibb & Sons, L.L.C.
$182
Incyte Corporation
$162
Genmab U.S., Inc.
$158
Celgene Corporation
$138
Ipsen Biopharmaceuticals, Inc
$99
Eisai Inc.
$86
Gilead Sciences, Inc.
$84
SHIELD THERAPEUTICS INC
$83
ARRAY BIOPHARMA INC
$82
Exelixis Inc.
$63
Takeda Pharmaceuticals U.S.A., Inc.
$54
Genentech USA, Inc.
$51
Lilly USA, LLC
$50
Janssen Pharmaceuticals, Inc
$49
SUN PHARMACEUTICAL INDUSTRIES INC.
$46
SOBI, INC
$46
Alnylam Pharmaceuticals Inc.
$44
Bayer Healthcare Pharmaceuticals Inc.
$42
Alexion Pharmaceuticals, Inc.
$41
TerSera Therapeutics LLC
$40
Adaptive Biotechnologies Corporation
$27
Agios Pharmaceuticals, Inc.
$20
Regeneron Healthcare Solutions, Inc.
$19
Stemline Therapeutics Inc.
$18
Janssen Biotech, Inc.
$18
GlaxoSmithKline, LLC.
$17
Sirtex Medical Inc
$14
Mirati Therapeutics, Inc.
$13
Top 3 companies account for 93.0% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$227,791
Daiichi Sankyo Inc.
$75,763
Genentech USA, Inc.
$7,311
Seagen Inc.
$4,027
Merck Sharp & Dohme LLC
$2,788
Astellas Pharma US Inc
$2,169
AstraZeneca UK Limited
$2,055
Eisai Inc.
$1,838
E.R. Squibb & Sons, L.L.C.
$1,199
Lilly USA, LLC
$1,048
PFIZER INC.
$898
Celgene Corporation
$746
Amgen Inc.
$723
Novartis Pharmaceuticals Corporation
$703
Incyte Corporation
$636
Janssen Biotech, Inc.
$574
Janssen Pharmaceuticals, Inc
$538
Pharmacyclics LLC, An AbbVie Company
$503
BeiGene, Ltd.
$450
GENZYME CORPORATION
$392
Seattle Genetics, Inc.
$367
Merck Sharp & Dohme Corporation
$327
Takeda Pharmaceuticals U.S.A., Inc.
$316
ABBVIE INC.
$290
Ipsen Biopharmaceuticals, Inc
$266
Exelixis Inc.
$253
Taiho Oncology, Inc.
$217
Puma Biotechnology, Inc.
$196
EMD Serono, Inc.
$191
Foundation Medicine, Inc.
$182
Genmab U.S., Inc.
$176
ARRAY BIOPHARMA INC
$176
Servier Pharmaceuticals LLC
$159
Pharmacyclics LLC, an AbbVie Company
$158
Gilead Sciences, Inc.
$151
Pharmacosmos Therapeutics Inc.
$149
EISAI INC.
$142
Bayer HealthCare Pharmaceuticals Inc.
$136
Regeneron Healthcare Solutions, Inc.
$114
Mirati Therapeutics, Inc.
$110
Medtronic, Inc.
$108
TerSera Therapeutics LLC
$97
GlaxoSmithKline, LLC.
$94
Alnylam Pharmaceuticals Inc.
$85
MorphoSys, US Inc.
$84
Blueprint Medicines Corporation
$84
AbbVie, Inc.
$83
SHIELD THERAPEUTICS INC
$83
Lexicon Pharmaceuticals, Inc.
$80
AMAG Pharmaceuticals, Inc.
$79
Kyowa Kirin, Inc.
$75
Teva Pharmaceuticals USA, Inc.
$72
SOBI, INC
$71
SUN PHARMACEUTICAL INDUSTRIES INC.
$68
BeiGene USA, Inc.
$68
Clovis Oncology, Inc.
$60
Alexion Pharmaceuticals, Inc.
$58
G1 Therapeutics, Inc.
$58
Sobi, Inc
$56
Karyopharm Therapeutics Inc.
$45
Bayer Healthcare Pharmaceuticals Inc.
$42
Agios Pharmaceuticals, Inc.
$42
PUMA BIOTECHNOLOGY, INC.
$41
Dova Pharmaceuticals
$40
Fresenius Kabi USA, LLC
$39
Stemline Therapeutics Inc.
$37
AVEO Pharmaceuticals, Inc.
$36
PharmaEssentia USA Corporation
$35
Heron Therapeutics, Inc.
$35
Kite Pharma, Inc.
$34
Boehringer Ingelheim Pharmaceuticals, Inc.
$34
Prometheus Laboratories Inc.
$33
Coherus Biosciences Inc.
$32
Immunomedics, Inc.
$30
Rigel Pharmaceuticals, Inc.
$30
Aveo Pharmaceuticals, Inc.
$30
Adaptive Biotechnologies Corporation
$27
AbbVie Inc.
$24
Secura Bio, Inc.
$24
Telix Pharmaceuticals
$22
Sandoz Inc.
$22
Acceleron Pharma, Inc.
$20
Octapharma USA, Inc.
$20
Jazz Pharmaceuticals Inc.
$18
TESARO, Inc.
$18
Helsinn Therapeutics (U.S.), Inc.
$17
JAZZ PHARMACEUTICALS INC.
$17
NOVARTIS PHARMACEUTICALS CORPORATION
$16
TAIHO ONCOLOGY, INC.
$16
Myovant Sciences Inc.
$15
RECORDATI_RARE_DISEASES_INC.
$15
EUSA Pharma (US) LLC
$15
Sirtex Medical Inc
$14
MEDIVATION FIELD SOLUTIONS LLC
$14
Sumitomo Pharma America, Inc.
$13
INSYS Therapeutics Inc
$13
Bio Products Laboratory USA, Inc.
$10
Top 3 companies account for 91.8% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALUNBRIG · AYVAKIT · Abraxane · Alecensa · Aranesp · Avastin · BALVERSA · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CAMZYOS · CARBAGLU · COSELA · CYRAMZA · Cabometyx · Chameleon · Coagadex · DARZALEX · DIFICID · DOPTELET · Doptelet · ELIQUIS · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · EPKINLY · ERBITUX · ERLEADA · EVENITY · EXKIVITY · Enhertu · Epkinly · Erleada · FARESTON · FARYDAK · FERAHEME · FOTIVDA · FOUNDATIONONE · Fabhalta · Farydak · GAVRETO · GAZYVA · GILOTRIF · GIVLAARI · Gazyva · Halaven · Herceptin · IBRANCE · ILLUCCIX · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · Idhifa · Imbruvica · Itovebi · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kabiven · Kadcyla · Kyprolis · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LORBRENA · LUMAKRAS · LUPRON DEPOT · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · Monoferric · NERLYNX · NINLARO · NOXAFIL · Nerlynx · Neulasta · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Odomzo · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PYRUKYND · Padcev · Perjeta · Phesgo · Pomalyst · Proleukin · Prolia · REBLOZYL · RETEVMO · Reblozyl · Revlimid · Rubraca · SANCUSO · SANDOSTATIN · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SUSTOL · SUTENT · SYNDROS · Sodium Chloride · Somatuline Depot · Stivarga · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TECENTRIQ · TEPMETKO · TIBSOVO · TUKYSA · Tavalisse · Tivdak · Trodelvy · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · VYXEOS · Venclexta · Vitrakvi · Vyloy · XALKORI · XARELTO · XERMELO · XOSPATA · XPOVIO · XTANDI · Xermelo · Xospata · Xtandi · YONSA · ZEJULA · ZEPZELCA · ZIEXTENZO · ZOLADEX · ZYTIGA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (94%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology & oncology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for hematology & oncology in PA.
Geographic Context
Hematology & oncology specialists within 10 mi
289
Per 100K population
50.2
County median income
$88,576
Nearest hospital
BRYN MAWR HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Gupta is a mixed practice specialist, with above-average Medicare volume (top 1% in PA), with speaking/promotional industry engagement in the top 2% of PA peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Gupta experienced with darbepoetin injection (aranesp) for anemia?
Based on Medicare claims data, Dr. Gupta performed 95,900 darbepoetin injection (aranesp) for anemia services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gupta receive payments from pharmaceutical companies?
Yes. Dr. Gupta received a total of $338,679 from 97 companies across 1,288 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gupta's costs compare to other hematology & oncology specialists in Bryn Mawr?
Dr. Gupta's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gupta) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Bryn Mawr
Browse hematology & oncology specialists in Bryn Mawr ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in PA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in PA
Which PA hematology & oncology specialists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Daiichi Sankyo Inc. Payments to Doctors
See all physicians who received payments from Daiichi Sankyo Inc.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology